Sign In
Buy GRFS
$7.18
-0.100 (-1.37%)
At Close: Jun 23, 2026
Mason Capital Management Sends Letter to Spanish National Securities Market Commission Regarding Lack of Transparency by Grifols
10:00am, Monday, 13'th Jan 2025
NEW YORK--(BUSINESS WIRE)--Mason Capital Management LLC (“Mason”), a registered investment advisor to funds and accounts holding approximately 2.5% of Grifols S.A. (“Grifols” or the “Company
Flat Footed Calls for Prompt Governance Overhaul at Grifols
12:23pm, Tuesday, 10'th Dec 2024
BARCELONA, Spain--(BUSINESS WIRE)--Flat Footed LLC is the investment manager for FF Hybrid LP, Flat Footed Series LLC - Fund 3, and GP Recovery Fund LLC (collectively, with Flat Footed LLC, “Flat Fo
Mason Capital Management Requests Immediate Disclosure of Important Information Regarding Conflicted Grifols Director Tomas Daga
02:30am, Wednesday, 04'th Dec 2024
NEW YORK--(BUSINESS WIRE)--Mason Capital Management LLC (“Mason”), a registered investment advisor to funds and accounts holding approximately 2.1% of Grifols S.A. (“Grifols” or the “Company
Statement From Araoz y Rueda on Behalf of Certain Institutional Investors in Grifols
02:00am, Wednesday, 04'th Dec 2024
MADRID--(BUSINESS WIRE)--Law firm Araoz y Rueda has been independently engaged by several international and Spanish institutions (the “Clients”) holding in aggregate 5.65% of A shares and 3.88% of
Grifols: More Attractive Than In A Very Long Time
12:30pm, Friday, 29'th Nov 2024
I don't divest unless the fundamental thesis changes; Grifols' buyout offer from Brookfield Asset Management is undervalued, so I maintain my "Buy" stance. Despite Brookfield's offer, I believe Grifol
Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday?
09:29am, Friday, 29'th Nov 2024
On Wednesday, Grifols SA GRFS said it ended discussions with Brookfield Capital Partners (UK) Limited about a potential acquisition.
Grifols Stock Declines After Brookfield Drops Buyout Offer
11:06am, Thursday, 28'th Nov 2024
Brookfield decides to drop its buyout offer for GRFS following discrepancies over the company's valuation.
Grifols shares tumble after report on Brookfield abandoning takeover plan
03:25am, Wednesday, 27'th Nov 2024
Shares in Grifols were falling on Wednesday morning after Bloomberg reported Canadian fund Brookfield is considering dropping its plan to take over the Spanish pharmaceutical firm.
Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%
10:31am, Wednesday, 20'th Nov 2024
Per GRFS, Brookfield's offer to buy its entire outstanding share capital for 6.45 billion euros significantly undervalues GRFS' prospects and long-term potential.
Grifols: Brookfields potential $6.8 bln offer undervalues the firm
08:25am, Tuesday, 19'th Nov 2024
Grifols said on Tuesday that Canadian investment fund Brookfield's potential 6.45 billion euro ($6.8 billion) offer significantly undervalued the Spanish drugmaker's prospects and long-term potential.
Spanish court opens investigation into Gotham City's attack on Grifols
05:54am, Tuesday, 19'th Nov 2024
An investigating magistrate at the Spanish High Court said on Tuesday it had opened an investigation into U.S.-based short seller Gotham City's actions that brought down the share price of Spanish pha
Mason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of Directors
02:30am, Tuesday, 19'th Nov 2024
NEW YORK--(BUSINESS WIRE)--Mason Capital Management LLC (“Mason”), a registered investment advisor to funds and accounts holding approximately 2.1% of Grifols S.A. (“Grifols” or the “Company
Brookfield mulls $7.4 bln bid for Spain's Grifols, El Confidencial says
02:58am, Monday, 18'th Nov 2024
Canadian fund Brookfield plans to offer about 7 billion euros ($7.4 billion) for Spanish drugmaker Grifols after finishing due diligence, news website El Confidencial reported on Monday, citing source
NEW YORK--(BUSINESS WIRE)--Mason Capital Management LLC (“Mason”), a registered investment advisor to funds and accounts holding approximately 2.1% of Grifols S.A. (“Grifols” or the “Company
Grifols on track to meet 2024 targets despite third-quarter profit drop
11:58am, Thursday, 07'th Nov 2024
Spanish drugmaker Grifols said on Thursday it was on track to meet its targets for the year after its net profit fell 7.5% in the third quarter from the same period a year ago.
